Ignite Creation Date:
2025-12-24 @ 3:25 PM
Ignite Modification Date:
2026-02-11 @ 5:44 AM
Study NCT ID:
NCT02487992
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2016-02-24
First Post:
2015-06-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Study of CIK Plus S-1 and Bevacizumab as Maintenance Treatment for Patients With Advanced Colorectal Cancer
Sponsor:
The First People's Hospital of Changzhou
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CZYY-CRC-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None